Conjunctival Goblet Cell Secretion Stimulated by Leukotrienes Is Reduced by Resolvins D1 and E1 To Promote Resolution of Inflammation
暂无分享,去创建一个
[1] C. Serhan,et al. Resolvin D1 binds human phagocytes with evidence for proresolving receptors , 2010, Proceedings of the National Academy of Sciences.
[2] B. Jessen,et al. Corneal Neovascularization and Ocular Irritancy Responses in Dogs Following Topical Ocular Administration of an EP4-Prostaglandin E2 Agonist , 2009, Toxicologic pathology.
[3] C. Serhan,et al. Resolvin E1 Receptor Activation Signals Phosphorylation and Phagocytosis* , 2009, The Journal of Biological Chemistry.
[4] S. Paruchuri,et al. Leukotriene E4–induced pulmonary inflammation is mediated by the P2Y12 receptor , 2009, The Journal of experimental medicine.
[5] R. Dana,et al. Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. , 2009, Investigative ophthalmology & visual science.
[6] Jeffrey A. Bair,et al. Stimulatory role of PKCalpha in extracellular regulated kinase 1/2 pathway in conjunctival goblet cell proliferation. , 2009, Investigative ophthalmology & visual science.
[7] William Farley,et al. Tear cytokine profiles in dysfunctional tear syndrome. , 2009, American journal of ophthalmology.
[8] Guoxing Wang,et al. Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis. , 2009, Differentiation; research in biological diversity.
[9] M. Toner,et al. Rapid Appearance of Resolvin Precursors in Inflammatory Exudates: Novel Mechanisms in Resolution1 , 2008, The Journal of Immunology.
[10] C. Serhan,et al. An endogenous regulator of inflammation, resolvin E1, modulates osteoclast differentiation and bone resorption , 2008, British journal of pharmacology.
[11] C. Serhan. Systems approach with inflammatory exudates uncovers novel anti-inflammatory and pro-resolving mediators. , 2008, Prostaglandins, leukotrienes, and essential fatty acids.
[12] B. Levy,et al. Resolvin E1 regulates interleukin 23, interferon-γ and lipoxin A4 to promote the resolution of allergic airway inflammation , 2008, Nature Immunology.
[13] J. Gu,et al. ERK/p44p42 mitogen-activated protein kinase mediates EGF-stimulated proliferation of conjunctival goblet cells in culture. , 2008, Investigative ophthalmology & visual science.
[14] Charles N. Serhan,et al. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators , 2008, Nature Reviews Immunology.
[15] T. Ishizuka,et al. Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma. , 2008, Biochemical and biophysical research communications.
[16] M. Stern,et al. Ocular anti‐allergic compounds selectively inhibit human mast cell cytokines in vitro and conjunctival cell infiltration in vivo , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[17] Lois E. H. Smith,et al. Increased dietary intake of ω-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis , 2007, Nature Medicine.
[18] Carolyn G. Begley,et al. The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). , 2007, The ocular surface.
[19] J. Gu,et al. Role of neurotrophins and neurotrophin receptors in rat conjunctival goblet cell secretion and proliferation. , 2007, Investigative ophthalmology & visual science.
[20] Christophe Baudouin,et al. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). , 2007, The ocular surface.
[21] J. Uddin,et al. Resolvin D1 and Its Aspirin-triggered 17R Epimer , 2007, Journal of Biological Chemistry.
[22] C. Serhan. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. , 2007, Annual review of immunology.
[23] J. Duffield,et al. Resolvin D Series and Protectin D1 Mitigate Acute Kidney Injury1 , 2006, The Journal of Immunology.
[24] B. Schultz,et al. Pharmacology of ocular allergy , 2006, Current opinion in allergy and clinical immunology.
[25] B. Levy,et al. RvE1 protects from local inflammation and osteoclastmediated bone destruction in periodontitis , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[26] Makoto Arita,et al. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[27] A. Sher,et al. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1 , 2005, The Journal of experimental medicine.
[28] Santa Jeremy Ono,et al. Allergic conjunctivitis: update on pathophysiology and prospects for future treatment. , 2005, The Journal of allergy and clinical immunology.
[29] V. Capra. Molecular and functional aspects of human cysteinyl leukotriene receptors. , 2004, Pharmacological research.
[30] Heung-Man Lee,et al. Up-regulation of MUC5AC and MUC5B mucin genes in chronic rhinosinusitis. , 2004, Archives of otolaryngology--head & neck surgery.
[31] M. Parmentier,et al. The C-terminal Nonapeptide of Mature Chemerin Activates the Chemerin Receptor with Low Nanomolar Potency* , 2004, Journal of Biological Chemistry.
[32] D. Dartt. Control of mucin production by ocular surface epithelial cells. , 2004, Experimental eye research.
[33] R. Hodges,et al. Isolation and characterization of cultured human conjunctival goblet cells. , 2003, Investigative ophthalmology & visual science.
[34] D. Zoukhri,et al. Activation of mitogen-activated protein kinase by cholinergic agonists and EGF in human compared with rat cultured conjunctival goblet cells. , 2003, Investigative ophthalmology & visual science.
[35] G. Rasi,et al. Montelukast, a leukotriene receptor antagonist, in vernal keratoconjunctivitis associated with asthma. , 2003, Archives of ophthalmology.
[36] D. Zoukhri,et al. Cholinergic agonists transactivate EGFR and stimulate MAPK to induce goblet cell secretion. , 2003, American journal of physiology. Cell physiology.
[37] D. Rogers. The airway goblet cell. , 2003, The international journal of biochemistry & cell biology.
[38] G. Scadding,et al. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. , 2002, The New England journal of medicine.
[39] C. Serhan,et al. Resolvins , 2002, The Journal of experimental medicine.
[40] N. Nieto,et al. Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis. , 2002, The Journal of nutrition.
[41] D. Zoukhri,et al. Regulation of conjunctival goblet cell secretion by Ca(2+)and protein kinase C. , 2000, Experimental eye research.
[42] C. Clish,et al. Novel Functional Sets of Lipid-Derived Mediators with Antiinflammatory Actions Generated from Omega-3 Fatty Acids via Cyclooxygenase 2–Nonsteroidal Antiinflammatory Drugs and Transcellular Processing , 2000, The Journal of experimental medicine.
[43] D. Dartt,et al. Development of conjunctival goblet cells and their neuroreceptor subtype expression. , 2000, Investigative ophthalmology & visual science.
[44] D. Zoukhri,et al. Immunolocalization of muscarinic and VIP receptor subtypes and their role in stimulating goblet cell secretion. , 1999, Investigative ophthalmology & visual science.
[45] C. D. Richardson,et al. 5-lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase. , 1993, European journal of biochemistry.
[46] C. Labat,et al. A second cysteinyl leukotriene receptor in human lung. , 1992, The Journal of pharmacology and experimental therapeutics.
[47] D. Woodward,et al. Platelet-activating factor causes goblet cell depletion in the conjunctiva. , 1989, European journal of pharmacology.
[48] S. Dahlén,et al. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. , 1987, Science.